Pay in 4 interest-free payments of $6.10 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
In published research protocols, BPC-157 has been studied across a dosing range of 1-10 mcg/kg in animal models, with the majority of positive results observed at doses between 2-10 mcg/kg administered intraperitoneally or subcutaneously
Human clinical trials, though limited, have demonstrated a potential decrease in substance use among patients treated with GLP-1RAs, particularly for alcohol and tobacco use disorders
BPC-157 acts as a master signaling molecule, with microarray analysis revealing a 7-fold up-regulation of Growth Hormone Receptor (GHR) in tendon fibroblasts by the third day of treatment
[4] Patients with benzyl alcohol allergy should not be exposed to this diluent
US$ 25.04
US$ 21.10
US$ 22.20
US$ 29.11
